Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$8,896 Mln
Revenue (TTM)
$13,184 Mln
Net Profit (TTM)
$398 Mln
ROE
0.1 %
ROCE
6 %
P/E Ratio
23.1
P/B Ratio
2.7
Industry P/E
--
EV/EBITDA
12.3
Div. Yield
0 %
Debt to Equity
--
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
114,704,121
CFO
$6,089.60 Mln
EBITDA
$9,856.52 Mln
Net Profit
$4,903.68 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Henry Schein (HSIC)
| -3.3 | -5.3 | -4.6 | 1.8 | -1.8 | 1.5 | 1.2 |
|
BSE Sensex
| -9.4 | -8.1 | -9.3 | 3.4 | 9.8 | 9.0 | 12.0 |
|
S&P Midcap 400
| 0.5 | -5.8 | 1.7 | 13.2 | 12.3 | 4.8 | 9.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Henry Schein (HSIC)
| 9.2 | -8.5 | -5.2 | 3.0 | 16.0 | 0.2 | 8.4 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Henry Schein (HSIC)
|
73.1 | 8,896.5 | 13,184.0 | 398.0 | 5.2 | 12 | 23.1 | 2.7 |
| 108.5 | 187,721.9 | 44,328.0 | 6,524.0 | 20.0 | 13.1 | 29 | 3.6 | |
| 158.1 | 57,735.4 | 21,923.0 | 1,757.0 | 12.0 | 6.9 | 26 | 1.8 | |
| 71.3 | 102,581.0 | 20,074.0 | 2,886.0 | 14.7 | 12.5 | 35.6 | 4.2 | |
| 191.5 | 132,461.4 | 24,568.0 | 3,614.0 | 18.3 | 7.1 | 37.2 | 2.9 | |
| 86.6 | 11,465.4 | 2,938.9 | 537.9 | 18.3 | 12.3 | 21.6 | 2.5 | |
| 477.7 | 167,678.3 | 10,064.7 | 2,856.0 | 29.3 | 16.7 | 59.8 | 9.5 | |
| 27.4 | 26,640.6 | 17,834.0 | 895.0 | 8.5 | 7.8 | 26 | 2.1 | |
| 345.8 | 128,878.1 | 25,116.0 | 3,246.0 | 17.9 | 15.1 | 40.1 | 5.8 | |
| 464.7 | 172,506.1 | 44,556.0 | 6,737.0 | 19.5 | 13.1 | 26.2 | 3.3 |
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The... Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York. Read more
Executive Chairman & CEO
Mr. Stanley M. Bergman
Senior VP & CFO
Mr. Ronald N. South
Headquarters
Melville, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Henry Schein Inc (HSIC) is $73.12 (NASDAQ) as of 18-Mar-2026 16:00 EDT. Henry Schein Inc (HSIC) has given a return of -1.82% in the last 3 years.
The P/E ratio of Henry Schein Inc (HSIC) is 23.11 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
22.47
|
2.76
|
|
2024
|
22.29
|
2.56
|
|
2023
|
23.79
|
2.71
|
|
2022
|
20.17
|
3.15
|
|
2021
|
17.44
|
3.18
|
The 52-week high and low of Henry Schein Inc (HSIC) are Rs 89.29 and Rs 60.56 as of 19-Mar-2026.
Henry Schein Inc (HSIC) has a market capitalisation of $ 8,896 Mln as on 13-Mar-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in Henry Schein Inc (HSIC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$-1.75
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.